NDC 68084-400-11 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-400
- Requested NDC
- 68084-400-11
- Package NDCs from labels
- 68084-400-11, 68084-400-01
- Manufacturer
- American Health Packaging
- Effective date
- 2022-08-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - American Health Packaging | American Health Packaging | 2022-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Cardinal Health | Cardinal Health | 2020-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-400-01 | EA - Each | 68084-400 | 41666e81-15c3-4690-94fc-d92d4134a63a | 1 | 2012-07-24 |
| 68084-400-11 | EA - Each | 68084-400 | b155c5bf-da98-4fc7-9851-e4e846ffd22d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 3688227b-7655-40ca-b34b-073a39fd60f4 | 2026-01-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | f330b7a0-bbe0-0f00-e053-2a95a90a37b8 | 2026-01-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 3f7dc283-b168-8251-e063-6294a90a45a2 | 2025-12-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 3f7da2a3-ca46-d3e8-e063-6294a90abef3 | 2025-12-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Chartwell RX, LLC | e464c8dd-5222-4a6b-b7e9-ca608a403c6e | 2025-12-22 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Accord Healthcare, Inc. | 61496a1e-17bf-4f45-a20c-5bb98fe545ee | 2025-12-16 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | AvKARE | 94471401-a516-0fe7-ec9c-447dd2bee972 | 2025-12-16 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Upsher-Smith Laboratories, LLC | 3ee6835a-7a7d-49a9-8460-2f1dd270ead3 | 2025-12-11 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Ajanta Pharma USA Inc. | 95c2a144-ba0d-4011-ae0f-0e0ca876e8a8 | 2025-11-30 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 44990ed6-b8e7-40f5-b636-e848024ec6d8 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 0697b3cf-b146-47c0-b5a5-5905ae8d1c97 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | VERITYRX, LLC | 427b6ffb-3ff4-932f-e063-6394a90ae8b9 | 2025-10-31 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | b5653b7e-1e3b-4da3-b3a2-33318f448c67 | 2025-10-20 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2025-10-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Major Pharmaceuticals | 7769ad3d-6228-4b2d-8f44-4efe990d3fad | 2025-09-19 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Cardinal Health 107, LLC | 8455b543-81ce-4522-ae9b-8396f944945c | 2025-08-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2025-08-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Major Pharmaceuticals | 7688cce8-797d-454c-95fb-52689741582e | 2025-07-15 | Warnings, Adverse reactions | L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.